Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

shutterstock 486831043

News and Trends 27 Jan 2017

Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin

Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone Lispro, an ultra-rapid insulin for diabetes. Despite results from 6 clinical studies indicating that Adocia’s ultra-rapid insulin performs better than Eli Lilly’s Humalog, the big American pharma has decided to terminate its collaboration with the French biotech. As part of this […]

January 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

artificial silk milk whey kth desy

News and Trends 27 Jan 2017

Researchers are One Step Closer to Understanding Artificial Silk

Silk is a material in high demand, and so is a method to produce it artificially. A Swedish-German team of researchers is studying how to make silk with milk whey protein. Besides making way for a potentially cheaper process, artificial silk could have important medical applications. Researchers from the Royal Institute of Technology (KTH) in Stockholm and […]

January 27, 2017 - 2 minutesmins - By Denise Neves Gameiro

shutterstock 546920338

News and Trends 26 Jan 2017

Europe’s Largest Biotech Actelion Seals the Deal with J&J for €28B

Actelion will be acquired by J&J for a whopping €27.9B, and its early R&D pipeline will be spun out into a new Switzerland-based outfit. The wait is over folks: Actelion, the largest biotech in Europe and one of the only 9 to make it to the billion-euro club in 2016, has just announced its acquisition by Johnson & Johnson for a […]

January 26, 2017 - 2 minutesmins - By Evelyn Warner

shutterstock 129344918

News and Trends 25 Jan 2017

Novartis Relies on Biotech to keep up its Solid Financial Performance

Novartis has announced excellent results for 2016. Could its strong focus on biotech be the key to the big pharma’s success? Novartis just released its 2016 financial report, boasting €45.2B ($48.5B) in net sales and its therapeutic antibody for psoriasis, Cosentyx (secukinumab), becoming a blockbuster. The Swiss pharma is suffering competition from generics, but it expects […]

January 25, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

shutterstock 327117671

News and Trends 25 Jan 2017

Update: From Lupus to a Vaccine for Diabetes Type I? Dates Announced

Update (25/01/2016): NeoVacs has announced plans to obtain preclinical proof of concept in 2017 for its type 1 diabetes program and to initiate clinical development in the first half of 2018 with the recommendation of its Scientific Advisory Board. Published on 13/10/2016 Neovacs has announced a research collaboration that could lead to the development of […]

January 25, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

shutterstock 558600136

News and Trends 25 Jan 2017

Genetically Engineered Mosquitoes will arrive in India to fight Dengue

Oxitec is preparing to start trials testing its solution to reduce the population of disease-transmitting insects in India with its own genetically modified mosquitoes. Oxitec, a spin-out from Oxford University, engineers mosquitoes to reduce their populations in areas where they spread infectious diseases. After success in Brazil and the Cayman Islands, the company is now heading […]

January 25, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT

Brekus

News and Trends 25 Jan 2017

Cryopreservation: Can you Cheat Death by Freezing Yourself?

Some people have already decided to take a leap of faith by cryogenically freezing themselves, often in the attempt to beat a yet incurable disease. Is science ready for it? And are we? Cryopreservation is a fairly common practice in sci-fi cinema. Several film directors – from Stanley Kubrick in his masterpiece “2001: A Space […]

January 25, 2017 - 4 minutesmins - By External Contributor

UC3 BioDan 3D printer human skin 2 e1485278338197

News and Trends 24 Jan 2017

Spanish Researchers Create a Human Skin 3D Printer

Scientists in Spain have created a 3D printer that uses bioink to recreate authentic human skin for drug testing and regenerative medicine applications. Researchers from the Universidad Carlos III de Madrid (UC3) and collaborators, including the Spanish bioengineering firm BioDan, have presented a prototype of a 3D printer that can create completely functional human skin. An industrial model could […]

January 24, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

shutterstock 519832192

News and Trends 24 Jan 2017

Smart Nebulizers for Children with Asthma are Underway

Vectura has received FDA approval to start testing a smart device to improve asthma therapies in children. Vectura, based in the UK, develops inhaled delivery technology for diseases that affect air tracts, such as cystic fibrosis, or influenza. The company has now received an investigational new drug (IND) approval from the FDA to study a […]

January 24, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

shutterstock 500279056

News and Trends 23 Jan 2017

French Biotech partners with Merck to Fight Tumor Resistance

Domain Therapeutics and Merck have partnered up to develop immuno-oncology drug candidates that can boost the performance of checkpoint inhibitors. Domain Therapeutics has entered a collaboration and licensing agreement with German Merck in immuno-oncology. The big pharma is offering over €240M in milestones and will support research activities in exchange for worldwide rights to new drug candidates targeting […]

January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2017 01 23 at 3.58.16 PM 1 e1485183691824

News and Trends 23 Jan 2017

New Fundraising Boosts Ultra-Rapid STD Detection

Atlas Genetics has raised €32.6M in Series D. The funds will help the company bring ultra-rapid diagnostic tests for STDs to the market. Atlas Genetics, a spin-off from the University of Bath, has closed an impressive €32.6M ($35M) Series D round of fundraising. The funds will support clinical trials, manufacturing and the commercial launch of the company’s second ultra-rapid […]

January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

shutterstock 522019321

News and Trends 23 Jan 2017

A Placebo beats the Largest European Biotech in Phase III

Actelion’s lead drug Opsumit has missed its primary endpoint in Phase III. What are the consequences for the biggest independent biotech in Europe? Actelion is a leader in treatments for pulmonary arterial hypertension (PAH). However, results from a Phase III trial evaluating Opsumit (macitentan) in patients with PAH due to Eisenmenger Syndrome have revealed that the drug […]

January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT